HZNP LTD has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BIO LIFE SCIENCE FORSCHUNGS & ENTWICKLUNGSGESELLSCHAFT MBH, MABPLEX INT LTD and MACREGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 20 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics | |
#4 | Peptides | |
#5 | Syringes | |
#6 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Singh Jagat | 16 |
#2 | Kisak Ed | 10 |
#3 | Shainhouse Joseph Zev | 6 |
#4 | Kisak Edward | 6 |
#5 | King-Smith Robert Dominic | 6 |
#6 | Grierson Lisa Marie | 6 |
#7 | Burian Maria | 6 |
#8 | Wilkin Jonathan | 6 |
#9 | Galer Bradley S | 6 |
#10 | Newsam John M | 5 |
Publication | Filing date | Title |
---|---|---|
WO2021041773A1 | Methods for the treatment of thyroid eye disease | |
WO2019173352A1 | Methods for the treatment of thyroid eye disease | |
US2019225696A1 | Methods for the treatment of thyroid eye disease | |
AU2016297583A1 | Combination of immunomodulatory agent with PD-1-or PD-L1 checkpoint inhibitors in the treatment of cancer |